Results 11 to 20 of about 7,281,051 (191)

Gitelman syndrome caused by a rare homozygous mutation in the SLC12A3 gene: A case report. [PDF]

open access: yesWorld J Clin Cases, 2020
BACKGROUND Gitelman syndrome (GS) is an unusual, autosomal recessive salt-losing tubulopathy characterized by hypokalemic metabolic alkalosis, hypomagnesemia and hypocalciuria.
Yu RZ, Chen MS.
europepmc   +4 more sources

Novel heterozygous missense mutation of SLC12A3 gene in Gitelman syndrome: A case report. [PDF]

open access: yesWorld J Clin Cases, 2019
BACKGROUND To screen for possible pathogenic loci in a patient with Gitelman syndrome by high-throughput exome sequencing and to explore the relationship between genotype and phenotype.
Wang CL.
europepmc   +4 more sources

Case report: Two novel compound heterozygous variant of SLC12A3 gene in a gitelman syndrome family and literature review. [PDF]

open access: yesFront Genet
A 36-year-old unmarried male chef was incidentally diagnosed with hypokalemia during an evaluation for an acute perianal abscess. Despite potassium supplementation, he developed progressive weakness in his lower limbs, culminating in an inability to ...
Ji X, Zhao N, Liu H, Wu Y, Liu L.
europepmc   +5 more sources

Complicated Gitelman syndrome and autoimmune thyroid disease: a case report with a new homozygous mutation in the SLC12A3 gene and literature review [PDF]

open access: yesBMC Endocrine Disorders, 2018
Background Gitelman syndrome (GS) is an inherited autosomal recessive renal tubular disorder characterized by low levels of potassium and magnesium in the blood, decreased excretion of calcium in the urine, and elevated blood pH.
Haiyang Zhou   +10 more
doaj   +3 more sources

Gitelman syndrome associated with chondrocalcinosis and severe neuropathy: a novel heterozygous mutation in SLC12A3 gene

open access: yesReumatismo, 2020
Gitelman syndrome (GS) is an inherited salt-wasting tubulopathy characterized by hypocalciuria, hypokalemia, hypomagnesemia and metabolic alkalosis, due to inactivating mutations in the SLC12A3 gene. Symptoms may be systemic, neurological, cardiovascular,
E. Conticini   +6 more
doaj   +9 more sources

Exonic mutations in the SLC12A3 gene cause exon skipping and premature termination in Gitelman syndrome. [PDF]

open access: yesJ Am Soc Nephrol, 2015
A variety of genetic backgrounds cause the loss of function of thiazide-sensitive sodium chloride cotransporter, encoded by SLC12A3, responsible for the phenotypes in Gitelman syndrome. Recently, the phenomenon of exon skipping, in which exonic mutations result in abnormal splicing, has been associated with various diseases.
Takeuchi Y   +13 more
europepmc   +5 more sources

A Pedigree with c.179 Cytosine to Threonine Missense Mutation of SLC12A3 Gene Presenting Gitelman's Syndrome. [PDF]

open access: yesElectrolyte Blood Press, 2016
A 42-year-old man came to the hospital presenting chest discomfort and general weakness. He had come to the hospital with the same symptoms 3 months ago and 12 years prior. His laboratory test showed hypokalemia, hypomagnesemia and hypocalciuria.
Kim Y   +5 more
europepmc   +4 more sources

Novel heterozygous mutations of SLC12A3 gene in a Chinese pedigree with Gitelman syndrome: A care-compliant case report. [PDF]

open access: yesMedicine (Baltimore), 2023
Rationale: The diagnosis of Gentleman syndrome (GS) is usually delayed because the clinical symptoms are easily mistaken. Patient concerns: A 19-year-old male patient was referred to endocrinology due to intermittent twitch of extremities for ...
Bi Y, Kuang MY, Li ML.
europepmc   +2 more sources

CRISPR-Cas9-Mediated Correction of SLC12A3 Gene Mutation Rescues the Gitelman's Disease Phenotype in a Patient-Derived Kidney Organoid System. [PDF]

open access: yesInt J Mol Sci, 2023
The aim of this study is to explore the possibility of modeling Gitelman’s disease (GIT) with human-induced pluripotent stem cell (hiPSC)-derived kidney organoids and to test whether gene correction using CRISPR/Cas9 can rescue the disease phenotype of ...
Lim SW   +9 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy